Isolation and Identification of the Novel Tubulin Polymerization Inhibitor Bifidenone

  • J Nat Prod. 2017 Mar 24;80(3):616-624. doi: 10.1021/acs.jnatprod.6b00893.
Russell B Williams  1 Steven M Martin  1 Julie A Lawrence  1 Vanessa L Norman  1 Mark O'Neil-Johnson  1 Gary R Eldridge  1 Courtney M Starks  1
Affiliations
  • 1. Lead Discovery and Rapid Structure Elucidation Group, Sequoia Sciences, Inc. , 1912 Innerbelt Business Center Drive, St. Louis, Missouri 63114, United States.
Abstract

The pursuit of structurally novel compounds has led to the isolation of a series of neolignans (2-6), for which the structures have been determined from microgram quantities using microcryoprobe NMR technology. Compounds 2-6 provided some unexpectedly clear structure-activity relationship data, with compound 2 demonstrating significantly more potency in the in vitro cytotoxicity assay than the Other analogues. Further screening found that compound 2 induces Apoptosis with activation of Caspase 3/7. The NCI Compare algorithm suggested that compound 2 acts through the inhibition of tubulin/microtubule dynamics. Compound 2 was confirmed to be a tubulin polymerization inhibitor that binds directly to tubulin.